"Purpura, Thrombocytopenic, Idiopathic/drug therapy"[MAJR] - Search Results

Year	Number of Results
1991	10
1992	17
1993	17
1994	13
1995	26
1996	20
1997	13
1998	16
1999	18
2000	28
2001	27
2002	36
2003	49
2004	42
2005	45
2006	50
2007	49
2008	67
2009	96
2010	85
2011	74
2012	84
2013	68
2014	85
2015	86
2016	94
2017	85
2018	88
2019	102
2020	112
2021	179
2022	140
2023	152
2024	150
2025	70

1

Recent advances in the mechanisms and treatment of immune thrombocytopenia.

Provan D, Semple JW. Provan D, et al. EBioMedicine. 2022 Feb;76:103820. doi: 10.1016/j.ebiom.2022.103820. Epub 2022 Jan 21. EBioMedicine. 2022. PMID: 35074629 Free PMC article. Review.

2

Recent progress in ITP treatment.

Rodeghiero F. Rodeghiero F. Int J Hematol. 2023 Mar;117(3):316-330. doi: 10.1007/s12185-022-03527-1. Epub 2023 Jan 9. Int J Hematol. 2023. PMID: 36622549 Review.

3

Novel therapeutics and future directions for refractory immune thrombocytopenia.

Al-Samkari H, Neufeld EJ. Al-Samkari H, et al. Br J Haematol. 2023 Oct;203(1):65-78. doi: 10.1111/bjh.19078. Br J Haematol. 2023. PMID: 37735554 Free PMC article. Review.

4

Eltrombopag-associated erythromelalgia in idiopathic thrombocytopenic purpura.

Perez J, Khouri C, Park S, Imbert B, Cracowski JL. Perez J, et al. Br J Dermatol. 2022 Mar;186(3):585-586. doi: 10.1111/bjd.20829. Epub 2021 Nov 24. Br J Dermatol. 2022. PMID: 34698373 No abstract available.

5

Comparative efficacy of 19 drug therapies for patients with idiopathic thrombocytopenic purpura: a multiple-treatments network meta-analysis.

Zhou H, Fan J, He J, Hu S. Zhou H, et al. Ann Hematol. 2022 May;101(5):953-961. doi: 10.1007/s00277-022-04784-0. Epub 2022 Feb 12. Ann Hematol. 2022. PMID: 35149911

6

[Treatment of ITP].

Yokoyama K. Yokoyama K. Rinsho Ketsueki. 2021;62(8):1229-1235. doi: 10.11406/rinketsu.62.1229. Rinsho Ketsueki. 2021. PMID: 34497211 Japanese.

7

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials.

Bussel J, Arnold DM, Grossbard E, Mayer J, Treliński J, Homenda W, Hellmann A, Windyga J, Sivcheva L, Khalafallah AA, Zaja F, Cooper N, Markovtsov V, Zayed H, Duliege AM. Bussel J, et al. Am J Hematol. 2018 Jul;93(7):921-930. doi: 10.1002/ajh.25125. Epub 2018 May 15. Am J Hematol. 2018. PMID: 29696684 Free PMC article. Clinical Trial.

8

A phase 3, randomized, double-blind, active-controlled trial evaluating efficacy and safety of avatrombopag versus eltrombopag in ITP.

Tarantino MD, Bussel JB, Lee EJ, Jamieson BD. Tarantino MD, et al. Br J Haematol. 2023 Aug;202(4):897-899. doi: 10.1111/bjh.18908. Epub 2023 Jun 20. Br J Haematol. 2023. PMID: 37339869 Clinical Trial. No abstract available.

9

Daratumumab as a novel treatment option in refractory ITP.

Vernava I, Schmitt CA. Vernava I, et al. Blood Cells Mol Dis. 2023 Mar;99:102724. doi: 10.1016/j.bcmd.2023.102724. Epub 2023 Jan 13. Blood Cells Mol Dis. 2023. PMID: 36669360

10

MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages.

Cao J, Ji L, Zhan Y, Shao X, Xu P, Wu B, Chen P, Cheng L, Zhuang X, Ou Y, Hua F, Sun L, Li F, Chen H, Zhou Z, Cheng Y. Cao J, et al. Cell Mol Immunol. 2023 Dec;20(12):1413-1427. doi: 10.1038/s41423-023-01089-8. Epub 2023 Oct 13. Cell Mol Immunol. 2023. PMID: 37833401 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,012 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,012 results

Results by year